FR0000120271 (FR0000120271)

$169.0B
Market Cap
15.9
P/E Ratio
0.28
Beta
4.42%
Dividend Yield
Piotroski 5/9Altman Z 1.5 DistressBeneish M -2.79 CleanROIC−WACC +2.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.5.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency presents a modest spread, with the return on invested capital of 10.0% exceeding the weighted average cost of capital by only 2.9%, suggesting limited excess returns relative to financing costs. While earnings quality indicators appear robust under the Beneish M-Score framework at -2.79 and show moderate financial strength via a Piotroski F-Score of 5/9, the Altman Z-Score of 1.5 flags potential distress risks that warrant scrutiny. The DuPont decomposition reveals an operational challenge: despite healthy gross margins of 28.4% and net margins at 7.2%, revenue contraction of -6.8% YoY indicates deteriorating top-line momentum, which may be suppressing overall return on equity through declining asset turnover rather than margin compression or excessive leverage.

Valuation metrics currently sit near historical norms with a P/E ratio of 15.9x, yet the disconnect between this multiple and the DCF-derived fair value of $71 implies significant divergence from intrinsic worth based on current cash flow assumptions. The market appears to be pricing in limited growth expectations given the negative revenue trajectory, potentially creating a valuation floor if the DCF model's implied long-term growth rate aligns with sector peers or historical averages. However, without explicit data on peer multiples or specific discount rates used in the DCF calculation, it remains unclear whether the current market price reflects an efficient allocation of risk or a mispricing relative to the company's fundamental cash generation capabilities.

Risk assessment is further complicated by conflicting signals between profitability metrics and growth trends; while earnings quality scores suggest low manipulation risk, the Altman Z-Score proximity to insolvency thresholds introduces downside volatility that standard valuation multiples may not fully capture. The combination of shrinking revenues and a tight ROIC-WACC spread suggests an asset-light or mature business model struggling with market share erosion rather than capital efficiency gains. Investors must weigh whether the current P/E compression adequately compensates for the operational headwinds indicated by the revenue decline, as future performance hinges on reversing this contraction to restore margin expansion potential.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.1%9.1%
2%$76$58$39
3%$100$71$45
4%$148$92$53

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.1%, terminal growth 3%. Fair value $71 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.5
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.79
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

28.4%
Gross Margin
7.2%
Net Margin
10.0%
ROIC
7.1%
WACC
ROIC − WACC Spread: +2.9%— Positive spread.
-6.8%
Revenue Growth (YoY)
-16.7%
Earnings Growth (YoY)
10.4B
Free Cash Flow
78%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.48x
Debt / Equity
0.97x
Current Ratio
9.8x
Interest Coverage
0.6x
Net Debt / EBITDA
5.39%
FCF Yield
38.9B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $1.92
Act: $1.83
-4.6%
Q3
✗ Miss
Est: $1.61
Act: $1.57
-2.4%
Q2
✓ Beat
Est: $1.75
Act: $1.77
+0.9%
Q1
✗ Miss
Est: $1.78
Act: $1.73
-2.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

11.1
Forward P/E
PEG Ratio
1.71
Price/Book
5M
Avg Volume
$79.44
52W High
$47.65
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.0B
Tracked Passive Exposure
6
ETFs Holding FR0000120271
0.51%
Avg Weight in ETFs
$385B
Total ETF AUM

When investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell FR0000120271 shares regardless of FR0000120271's individual fundamentals. We estimate $2.0B of passive capital is structurally linked to FR0000120271 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in FR0000120271 to visualize passive redemption contagion across ETFs and collateral stocks.

FR0000120271 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
FR0000120271EpicenterIEFAETFEFAETFSCHFETFNL0010273215Low RiskCH0012032048Low RiskNVDALow RiskCH0012005267Low RiskAAPLLow Risk
FR0000120271 Price Drop (%)0

If FR0000120271 (FR0000120271) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with FR0000120271. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

FR0000120271 Ownership Dynamics

Ticker
FR0000120271

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

FR0000120271 Capital Efficiency

How efficiently does FR0000120271 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$10.4B
EBITDA
$38.9B
FCF Conversion
27%
Reinvestment Rate
73%
27% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
10.0%
ROIC − WACC Spread
2.9%

FR0000120271 converts 27% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 73% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 2.9% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare FR0000120271 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.